These findings suggest that hsa_circ_0007841 can promote a pattern of acquired chemoresistance in myeloma cells through the upregulation of ABCG2, providing a new molecular basis for chemotherapy in multiple myeloma (19). The gene discussed is ABCG2; the disease is plasma cell myeloma.